This programme is offered by the UCL Division of Medicine and the Wolfson Institute for Biomedical Research and is designed for the more research-oriented student, complementing Drug Design MSc. Conducting cutting-edge research within the drug industries and UCL's academic group, it offers opportunities for networking and future career development.
This programme teaches students the latest methodologies and approaches and covers all aspects of drug design: drug discovery, computational and structural biology, screening, assay development, medicinal chemistry, and most importantly the industrial practices involved in modern drug design technology.
Students undertake modules to the value of 180 credits.
The programme consists of two core modules (30 credits), three optional modules (45 credits) and a dissertation/report (105 credits).
Optional modules - students will select three from the following Drug Design MSc modules: -Bioinformatics and Structural Biology as applied to Drug Design -Biological Molecules as Therapeutics -Biophysical Screening Methods, X-ray Crystallography, Protein NMR and Phenotypic Screening -Cheminformatics and Modelling for Drug Design -Fragment-based Drug Design -Target Selection – Commercial and Intellectual Property Aspects -Target Selection – Scientific Grounds
Core modules - plus two taught transferable skills modules delivered by CALT (UCL Centre for the Advancement of Learning and Teaching): -Investigating Research -Researcher Professional Development
Dissertation/report All students undertake an independent research project which culminates in a dissertation of 15,000 to 20,000 words.
Teaching and learning The programme is delivered through a combination of lectures, seminars, tutorials and problem classes, critical journal clubs and a research project. Assessment is through coursework, practicals, laboratory work, examination, dissertation and oral presentation.
We expect students graduating from this programme to take leading roles in drug discovery and development worldwide or to undertake further PhD level research. The first cohort of students on the Drug Design MRes graduating in 2015 have found jobs in the pharmaceutical industry as well as PhD studentships in leading universities.
Employability The advanced knowledge and skill set acquired by taking this programme will enable students to find employment in the pharmaceutical and biotech industries in a global market.
Why study this degree at UCL?
The division hosts research groups in the areas of medicine, pharmaceutical research, cell cycle, neurobiology, mitochondrial function, stem cells and cancer. Underpinning the translational aspects of the biomedical research, we have a medicinal chemistry group which conducts research where chemistry and biology intersect, using the latest techniques and developing new ones for the study of biological systems.
The division collaborates extensively within industry and academia to develop biological tools and therapeutic agents. There are plenty of opportunities to conduct translational research that has an impact on drug discovery.
Pharmaceutical and biotech companies, well established in the West, have been transferring their research and development to the East. Given these substantial developments, particularly in China and India, the programme will have a broad international appeal.
Drug Design - MRes
page on the University College London website for more details!
An upper second-class UK Bachelor’s degree in a relevant subject (for example, life sciences, medicine, chemistry) or an overseas qualification of an equivalent standard, or an appropriate professional qualification, or a minimum of three years’ relevant work experience.
Recipient: University College London
Insert previous message below for editing?
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need. Why not add a message here